Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 14;5(9):e0973.
doi: 10.1097/CCE.0000000000000973. eCollection 2023 Sep.

Cerebral Vasospasm After Subarachnoid Hemorrhage: Respective Short-Term Effects of Induced Arterial Hypertension and its Combination With IV Milrinone: A Proof-of-Concept Study Using Transcranial Doppler Ultrasound

Affiliations

Cerebral Vasospasm After Subarachnoid Hemorrhage: Respective Short-Term Effects of Induced Arterial Hypertension and its Combination With IV Milrinone: A Proof-of-Concept Study Using Transcranial Doppler Ultrasound

Karim Lakhal et al. Crit Care Explor. .

Abstract

Objectives: It is unclear whether IV milrinone relaxes spasmed cerebral arteries and therefore reduces cerebral blood mean velocity (Vmean). In patients treated for cerebral vasospasm, we aimed to assess and delineate the respective impacts of induced hypertension and its combination with IV milrinone on cerebral hemodynamics as assessed with transcranial Doppler.

Design: Observational proof-of-concept prospective study.

Setting: ICU in a French tertiary care center.

Patients: Patients with aneurysmal subarachnoid hemorrhage who received induced hypertension (mean arterial blood pressure [MBP] of 100-120 mm Hg) and IV milrinone (0.5 µg/kg/min) for moderate-to-severe cerebral vasospasm. We excluded patients who underwent invasive angioplasty or milrinone discontinuation within 12 hours after the diagnosis of vasospasm.

Interventions: None.

Measurements and main results: Vmean was measured at vasospasm diagnosis (TDIAGNOSIS), after the induction of hypertension (THTN), and 1 (THTN+MILRINONE_H1) and 12 hours after the adjunction of IV milrinone (THTN+MILRINONE_H12). Thirteen patients were included. Median Vmean was significantly lower (p < 0.01) at THTN+MILRINONE_H1 (99 [interquartile range (IQR) 89; 134] cm.s-1) and THTN+MILRINONE_H12 (85 [IQR 73-127] cm/s) than at TDIAGNOSIS (136 [IQR 115-164] cm/s) and THTN (148 [IQR 115-183] cm/s), whereas TDIAGNOSIS and THTN did not significantly differ. In all patients but one, Vmean at THTN+MILRINONE_H1 was lower than its value at TDIAGNOSIS (p = 0.0005). Vmean-to-MBP and Vmean-to-cardiac output (CO) ratios (an assessment of Vmean regardless of the level of MBP [n = 13] or CO [n = 7], respectively) were, respectively, similar at TDIAGNOSIS and THTN but were significantly lower after the adjunction of milrinone (p < 0.01).

Conclusions: The induction of arterial hypertension was not associated with a significant decrease in Vmean, whereas the adjunction of IV milrinone was, regardless of the level of MBP or CO. This suggests that IV milrinone may succeed in relaxing spasmed arteries.

Keywords: Doppler; cerebrovascular circulation/drug effects; delayed ischemia; intracranial; milrinone; subarachnoid hemorrhage; transcranial; ultrasonography; vasospasm.

PubMed Disclaimer

Conflict of interest statement

Dr. Lakhal received, during the past 3 years, congress registration from Pfizer (once in 2022) and both congress registration and travel fees from Pfizer (once in 2020) and Advanz Pharma/Correvio (twice, in 2020 and once in 2021). Dr. Rozec received, during the past 5 years, lecture fees from Fisher and Paykel, Baxter, Laboratoire du Fractionnement et des Biotechnologies, and Aspen, research grants from Baxter and Aguettant, and consulting fees from Laboratoire du Fractionnement et des Biotechnologies, Aguettant, and Astra Zeneca. The remaining authors have not disclosed any potential conflicts of interest.

Figures

Figure 1.
Figure 1.
The main message of this figure is that the induction of arterial hypertension did not significantly affect blood mean velocity measured in the middle cerebral artery with trans-temporal Doppler (Vmean), whereas the adjunction of IV milrinone was associated with a significant decrease in Vmean. This finding was independent of the level of mean BP (n = 13) or CO (n = 7) as illustrated by the indexation of Vmean to these parameters. Respective effects of induced arterial hypertension and its combination with IV milrinone. The interquartile range (IQR) is calculated: IQR = third – first quartile. The upper inner fence box‑and‑whisker plots were constructed as follows: a box is drawn from the first to third quartile, and a horizontal line is drawn at the median, an imaginary line, is drawn at the third quartile + 1.5 × IQR. The horizontal line above the box is the highest measurement just below the upper inner fence. Similar lines are drawn at the lower side of the plot. A bracket indicates a significant difference (p < 0.01) between two timepoints. BP = arterial blood pressure, TDIAGNOSIS = at vasospasm diagnosis, THTN = 1 hr after the induction of hypertension, THTN+MILRINONE_H1 = 1 hr after the adjunction of IV milrinone, THTN+MILRINONE_H12 = 12 hr after the adjunction of IV milrinone.

References

    1. Claassen J, Park S: Spontaneous subarachnoid haemorrhage. Lancet Lond Engl 2022; 400:846–862 - PMC - PubMed
    1. Picetti E, Bouzat P, Bader MK, et al. : A survey on monitoring and management of cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage: The Mantra study. J Neurosurg Anesthesiol 2023. [Online Ahead of Print] - PubMed
    1. Bernier TD, Schontz MJ, Izzy S, et al. : Treatment of subarachnoid hemorrhage-associated delayed cerebral ischemia with milrinone: A review and proposal. J Neurosurg Anesthesiol 2021; 33:195–202 - PMC - PubMed
    1. Lakhal K, Hivert A, Alexandre P-L, et al. : Intravenous milrinone for cerebral vasospasm in subarachnoid hemorrhage: The MILRISPASM controlled before-after study. Neurocrit Care 2021; 35:669–679 - PubMed
    1. Velly LJ, Bilotta F, Fàbregas N, et al. ; European Neuroanaesthesia and Critical Care Interest Group (ENIG): Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage: A survey of European practice. Eur J Anaesthesiol 2015; 32:168–176 - PubMed

LinkOut - more resources